South Africa IT Industry Report 2020 with Profiles of Dimension Data, Datatec, EOH, Spark ATM Systems, Lumbro Time Systems, Intel, IBM and Cisco

PA Media: Sport
Manu Tuilagi signs new Sale contract
England centre has committed his future to Sale until 2023.
2 minutes ago
Yahoo Finance UK
Tech giant Darktrace heads for FTSE with £3bn IPO plan
The listing could be worth as much as £3bn ($4.3bn).
2 minutes ago
PA Media: Money
Wagamama boss to leave in June and ‘hand on chopsticks’ to internal successor
Emma Woods will step down on June 1 to focus on her career as a non-executive director on company boards.
2 minutes ago
Globe Newswire
COVID-19 Diagnostics and Kits: Global Markets
Report Scope: This report examines the current and future market potential of COVID-19 diagnostics. It offers an analysis of the competitive environment, regulatory scenario, technologies, and the drivers and restraints in the market’s growth.New York, April 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Diagnostics and Kits: Global Markets" - https://www.reportlinker.com/p06064339/?utm_source=GNW The report also covers market projections to 2025 and market rankings for key players. The report examines the market share of COVID-19 diagnostics based on type of products, type of testing and end user.This report segments the global market by four regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. The European region includes Germany, U.K., France, and the Rest of Europe. The Asia-Pacific region includes China, India, Japan and Rest of Asia-Pacific. For market estimates, data is provided for the base year of 2020 and forecast through year-end 2025.Report Includes:- 48 data tables and 34 additional tables- An overview of the global market for COVID-19 diagnostics and kits- Estimation of the market size and analyses of global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) though 2025- Evaluation of current market size and forecast, pipeline analysis of new products, and regulatory scenarios and detailed analysis of drivers, challenges and opportunities affecting market growth- Details about outbreak, symptoms, progression, incubation period and epidemiology of COVID-19; coverage of global confirmed COVID-19 cases and deaths; information on collaboration between organizations and governments; and impact of COVID-19 pandemic on medtech and medical tourism- A look at how pandemics adversely affect the health of the global population and destabilizes the world’s economies, social infrastructures, and geopolitical and natural environments- Highlights of the coronavirus treatment acceleration program (CTAP) and coverage of ongoing clinical trials of national regulatory agencies during the COVID-19 pandemic- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies- Comprehensive company profiles of major players of the industry, including Abbott, Becton, Dickinson and Co., Cepheid, Roche, PerkinElmer and Thermo Fisher ScientificSummary:The global market for COVID-19 Diagnostics was valued at REDACTED in 2020.The market is forecast to grow at a compound annual growth rate (CAGR) of REDACTED to reach REDACTED by 2025.For this report, the global market is segmented based on product type, testing type, end user and region.Reasons for Doing This Study:Pandemics are outbreaks of disease that become widespread via human-to-human infection.Recent disease outbreaks and pandemics include the Spanish flu, the Hong Kong flu, SARS, H7N9, Ebola and Zika (WHO, 2011b).The main features of a pandemic include broad geographic spread, disease movement, novelty, intensity, high attack rates and explosivity, limited population immunity, infectiousness and contagiousness.Pandemics have adversely affected the health of the planet’s inhabitants and have destabilized the world’s economies, social infrastructures, and geopolitical and natural environments.In China, in December 2019, the new coronavirus disease was detected for the first time. As of March2021, it continues to affect people across the globe. Early and accurate diagnosis of COVID-19 (the disease caused by an infection with the new coronavirus) is critical to controlling its spread and improving health outcomes.With the spread of COVID-19, the demand for molecular testing, which is considered the gold standard for diagnosing infectious disease, has increased. In the U.S. and Europe alone, the use of molecular diagnostics increased by 20% between March 2020 and October 2020. The volume of point-of-care (POC) testing has risen during the COVID-19 pandemic in response to demand for faster on-site screening. The response to that has been the accelerated development of new diagnostic technologies, such as next-generation sequencing (NGS) and CRISPR. Those technologies could soon challenge the leading position of the current RT-PCR systems for viral COVID-19 tests, particularly if regulators furtherfacilitate their rapid introduction.The growth of the global COVID-19 diagnostics market is being fueled by several factors, including the increasing numbers of COVID 19 cases; government and private funds to support the R&D of COVID-19 test kits and vaccines; the rising number of emergency use authorizations (EUAs) for diagnostic kits and devices; the growing geriatric population; and increasing support by non-medical device and diagnostics companies.Read the full report: https://www.reportlinker.com/p06064339/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
3 minutes ago
Reuters
Sterling rises to two-week high vs dollar ahead of data heavy calendar
"GBP continues to find support on dips and it seems like investors are happy enough staying positioned for the 2Q UK re-opening story," said Chris Turner, Global Head of Markets at ING. "Today we have already seen some encouraging April Rightmove house price data," he said.
3 minutes ago
Reuters
Firefighters battle to contain blaze on South Africa's Table Mountain
South African emergency workers have started evacuating three 17-storey residential buildings overlooking Cape Town city as a wildfire fanned by strong winds continues to burn out of control along Table Mountain, city officials said on Monday. The fire started early Sunday morning on the slopes of Devils' Peak, another part of Cape Town's mountainous backdrop, forcing University of Cape Town students to evacuate residences as runaway flames set several campus buildings ablaze, including a library housing historic books and scripts. Around 250 firefighters are battling to control the blaze, as strong winds ground helicopters normally used in firebombing sorties.
3 minutes ago
Associated Press
The Latest: EU to purchase 100 million more vaccine doses
Pharmaceutical company BioNTech and its U.S. partner Pfizer say they will provide 100 million more doses of their coronavirus vaccine to the European Union this year. The two companies said Monday that the 27-nation group’s executive Commission exercised an option to purchase the additional doses, bringing the total number of shots to be delivered to the EU in 2021 to 600 million. Sean Marett, the chief business officer of BioNTech, said deliveries of the company’s mRNA-based vaccine this year will cover two-thirds of the EU population.
4 minutes ago
Globe Newswire
Global Pharma, Biotech and Diagnostics Joint Venture Partnering Deal Terms and Agreements Analysis Report 2021
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading life science companies.This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of joint venture agreements from 2014.There is an increasing willingness for parties to enter joint venture deals; such deals enable both parties to benefit from the upside of a big product win, whereas traditional licensing deals forfeit upside for near term upfront, milestone and royalty payments.Joint venture partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.Another reason for joint venture deals is the joint origin of a project. Drug development projects often require various scientific and technological novelties that stem from different companies. If both companies contributed to the origination of the project, then both have from the beginning a stake in the project.The report provides a detailed understanding and analysis of how and why companies enter joint venture deals.Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.This report contains a comprehensive listing of all joint venture deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual joint venture contract documents as submitted to the Securities Exchange Commission by companies and their partners.Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 includes: Trends in joint venture dealmaking in the biopharma industry since 2014Analysis of joint venture deal structureCase studies of real-life joint venture dealsComprehensive listing of joint venture deals since 2014Access to joint venture contract documentsThe leading joint venture deals by value since 2014Most active joint venture dealmakers since 2014The leading joint venture partnering resources Available deals and contracts are listed by: Company A-ZHeadline valueTherapeutic areaTechnology type Analyzing actual contract agreements allows assessment of the following: What are the precise rights granted or optioned?What is actually granted by the agreement to the partner company?What exclusivity is granted?What is the payment structure for the deal?How do milestone align with clinical stage development phases?How are sales and payments audited?What is the deal term?How are the key terms of the agreement defined?How are IPRs handled and owned?Who is responsible for commercialization?Who is responsible for development, supply, and manufacture?How is confidentiality and publication managed?How are disputes to be resolved?Under what conditions can the deal be terminated?What happens when there is a change of ownership?What sublicensing and subcontracting provisions have been agreed?Which boilerplate clauses does the company insist upon?Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?Which jurisdiction does the company insist upon for agreement law? Key Topics Covered: Executive SummaryChapter 1 - IntroductionChapter 2 - Trends in joint venture partnerships2.1. Introduction2.2. Definition of joint venture deals2.3. Success factors for joint venture partnerships2.4. When joint venture partnerships can be useful2.5. Attributes of joint venture partnerships2.6. Aligning partners to make the joint venture work2.7. Trends in joint venture partnerships since 20142.7.1. Joint venture dealmaking by year, 2014 to 20212.7.2. Joint venture dealmaking by stage of development 2014 to 20212.7.3. Joint venture dealmaking by industry sector 2014 to 20212.7.4. Joint venture dealmaking by therapy area, 2014 to 20212.7.5. Joint venture dealmaking by technology type, 2014 to 20212.7.6. Joint venture dealmaking by most active company, 2014 to 20212.8. The future of joint venture partnershipsChapter 3 - Overview of joint venture deal structure3.1. Introduction3.2. Joint venture agreement structure3.3. Example joint venture agreements3.3.1. Case study 1: Agila Specialties - Pfenex3.3.2. Case study 2: Dance Biopharm - Harmony AssetChapter 4 - Leading joint venture deals4.1. Introduction4.2. Top joint venture deals by valueChapter 5 - Top 25 most active active joint venture dealmakers5.1. Introduction5.2. Top 25 most active joint venture dealmakersChapter 6 - Joint venture deals including contracts directory6.1. Introduction6.2. Joint venture deals with contracts 2014 to 2021For more information about this report visit https://www.researchandmarkets.com/r/9vy698 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
5 minutes ago
PA Media: Science
Nasa’s Ingenuity helicopter set for first ever controlled flight on Mars
The Ingenuity helicopter is expected to take to the Martian skies on Monday morning.
6 minutes ago
Reuters Videos
Tesla car crash kills two in Texas
Houston police say a deadly car crash involving a Tesla vehicle - was believed have been operating without a driver at the time of the incident on Saturday.The crash comes amid growing scrutiny over Tesla's semi-automated driving system following several recent accidents.According to local media reports, the 2019 Tesla Model S was moving at a high rate of speed when it failed to round a curve, speeding off the roadway, crashing into a tree and bursting into flames.Authorities say there was no one was in the driver's seat.After the fire was extinguished, authorities found one occupant in the front passenger seat, and one in the back.Tesla and the National Highway Traffic Safety Administration did not immediately respond to a request for comment.The U.S. auto safety agency said in March it has opened over two dozen investigations into crashes of Tesla vehicles, at least three of them recent.The latest accident could throw a wrench in Tesla's plans, as it prepares to launch its updated "full self-driving" software to more customers.In January, Tesla CEO Elon Musk said that he expects huge profits from the software, saying he was quote "highly confident the car will be able to drive itself… this year."
6 minutes ago
The Guardian
Pub and restaurant bosses launch legal battle over Covid rules
Pub and restaurant bosses launch legal battle over Covid rules. High court judge to consider whether venues in England should be allowed indoor seating
7 minutes ago
Globe Newswire
Prepayments (CK93) - Totalkredit A/S
To the Nasdaq Copenhagen 19 April 2021 Prepayments (CK93) Pursuant to s 24 of the Danish Capital Markets Act, Totalkredit A/S hereby publishes prepayment data (CK93) as at 16 April 2021 in the attached file. Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/en-gb/investor-relations/financial_reporting/prepayments/. For further information about data format and contents, please refer to the Nasdaq website. Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21. Yours sincerelyTotalkredit A/S Attachments Prepayments - Totalkredit A_S - 19-04-2021 eordindftk
8 minutes ago
Globe Newswire
Prepayments (CK93) - Nykredit Realkredit A/S
To the Nasdaq Copenhagen 19 April 2021 Prepayments (CK93) Pursuant to s 24 of the Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes prepayment data (CK93) as at 16 April 2021 in the attached file. Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/en-gb/investor-relations/financial_reporting/prepayments/. For further information about data format and contents, please refer to the Nasdaq website. Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21. Yours sincerelyNykredit Realkredit A/S Attachments Prepayments - Nykredit Realkredit A_S - 19-04-2021 eordindf
8 minutes ago
Globe Newswire
GLOBAL FLAVONOID MARKET FORECAST 2021-2028
KEY FINDINGS The global flavonoid market is anticipated to progress with a CAGR of 4. 19% during the forecast period of 2021 to 2028. Factors such as the use of flavonoids as an anticancer drug, the potential of plant-derived flavonoids in nutraceuticals, the demand for beauty and health supplements, and untapped markets across developing nations are among the key factors associated with the global market’s growth.New York, April 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL FLAVONOID MARKET FORECAST 2021-2028" - https://www.reportlinker.com/p06064349/?utm_source=GNW MARKET INSIGHTSFlavanols are characterized as a group of compounds found in apples, cocoa, tea, and several other plant-based products.The global market is essentially fueled by the increasing consumer demand for nutraceuticals, harboring the potential for plant flavonoids.Moreover, the launch of multiple products within the cosmetics sector will also significantly impact the demand for flavonoids. The major types of flavonoids entail anthocyanin, flavanone, and flavonol, among others.Flavonoids act as powerful antioxidants by providing remarkable protection against free-radical and oxidative damage.The compounds have also been recognized for their anti-allergic, hepatoprotective, anti-viral, anti-inflammatory, anti-carcinogenic, and anti-thrombotic characteristics.For instance, kaempferol, morin, quercetin, myricetin, and rutin, by acting as antioxidants, displayed advantageous effects, like anti-inflammatory, anti-allergic, and others.REGIONAL INSIGHTSThe global flavonoid market growth analysis includes the assessment of North America, the Asia-Pacific, Europe, and the Rest of World.The Asia-Pacific is set to lead the global market, owing to key factors like the rising demand from cancer-fighting products, the developing trend of various food colorants’ applications within the food and beverages industry, and transitioning food consumption patterns across Asia.In addition, the increasing demand for functional ingredients products further fuels the region’s market growth.COMPETITIVE INSIGHTSThe flavonoids market is continually growing, with several enterprises attempting to gain a substantial competitive advantage through the use of such ingredients in their products and innovation.Moreover, regional players also establish efforts in order to augment the current supply chain and ensure an improved product distribution.As a result, the industrial rivalry is expected to be intense.Some of the leading companies operating in the market are Bioriginal Food & Science Corp, Bordas SA, Cayman Chemical Company, etc.Our report offerings include:• Explore key findings of the overall market• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions• Market Segmentation cater to a thorough assessment of key segments with their market estimations• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developmentsCompanies mentioned1. ASHLAND GLOBAL HOLDINGS2. BORDAS SA 3. BIORIGINAL FOOD AND SCIENCE CORP4. CAYMAN CHEMICAL COMPANY5. EXTRASYNTHESE 6. FOODCHEM INTERNATIONAL CORPORATION7. INDENA SPA 8. MERCK KGAA 9. QUERCEGEN PHARMACEUTICALSRead the full report: https://www.reportlinker.com/p06064349/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
8 minutes ago
Business Wire
Global Primary Lithium Battery Market Insights (2020 to 2025) - Companies Include Panasonic, Maxell and Toshiba Among Others - ResearchAndMarkets.com
The "Primary Lithium Battery Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com's offering.
8 minutes ago
The Independent
6 best water flossers for deeper cleaning and healthy gums
Forget the old, fiddly methods – keep your smile fresh with these top devices
8 minutes ago
HuffPost
Matthew McConaughey Trounces Greg Abbott In Poll For Texas Governor
Not everyone's thrilled.
9 minutes ago
Red
The sweet moment Prince Harry and Prince William left the funeral together
They haven't been seen together since Prince Harry's interview with Oprah
9 minutes ago
Bloomberg
New Lithium Giant Emerges to Feed Surging Battery Demand
(Bloomberg) -- A planned $3.1 billion merger of two Australian miners is set to create one of the world’s biggest producers of lithium products key to meeting fast-growing global demand for electric vehicle batteries.The deal between Orocobre Ltd. and Galaxy Resources Ltd. is the biggest mining sector deal of the year so far, according to Bloomberg data, with shares of both companies closing at the highest in three years in Sydney. The merger would create the world’s fifth-biggest producer of lithium chemicals, the refined form of the raw materials that are used to make electric vehicle batteries.Miners to battery makers have rushed to secure lithium supply amid expectations the EV frenzy will create a structural deficit as soon as this year, and prices are already roaring back after a three-year slump. Battery demand is expected to surge tenfold by 2030, according to BloombergNEF, as the global clean-energy transition accelerates.The new company “is going to be a globally relevant player in terms of lithium chemical production,” said Reg Spencer, head of mining research at Canaccord Genuity Australia Ltd. He said that it could grow to be number three producer by 2025 if all growth projects go ahead.The A$4 billion deal values Galaxy at about A$3.53 a share, a 2.2% discount to Friday’s close, and has the backing of both company boards. Orocobre’s Chief Executive Officer Martin Perez de Solay will head the new group.Orocobre will offer 0.569 of its shares for every Galaxy share and will own 54.2% of the merged company, with Galaxy holding 45.8%. Orocobre was advised on the deal by UBS AG, while Galaxy’s adviser was Standard Chartered Plc. The deal is targeted for completion in mid August 2021.Diverse AssetsThe merged group, which has yet to be formally named, will have its headquarters in Buenos Aires, but its primary share listing will remain in Australia.The deal gives the companies a geographically diversified set of assets. Orocobre sells lithium carbonate from its Olaroz operation in Argentina, while Galaxy has a mine in Australia and growth projects in Canada and South America.Lithium raw materials are most commonly extracted at brine operations which pump liquid from underground reservoirs into vast evaporation ponds, or in traditional hard rock mines. China is the biggest player in electric vehicle batteries, with the majority of the world’s production capacity, and has a stranglehold over processing of the required commodities.The growth profile of the combined group’s existing assets put it on track to grab a 10% share of the lithium market over the next five to seven years, Perez de Solay said in an interview, backed by “a strong balance sheet that will enable us not only to deliver those projects but to continue to grow.” Top global lithium producers currently include Sociedad Quimica y Minera de Chile SA and Albemarle Corp.Argentina RiskCanaccord’s Spencer said there were risks in having the largest part of an operation in Argentina, given its history of geo-political and financial volatility, although Orocobre’s local management team had so far proven adept at navigating those risks.“From Galaxy’s perspective, we were looking for a partner which had deep in-country Argentinian experience and we’ve got that in Orocobre,” said Simon Hay, Galaxy’s CEO, who will take on the role of president of international business in the new organization. The merger will help to de-risk Galaxy’s Sal de Vida growth project in the South American country, he said.(Updates to add lithium chemicals and processing information in second, ninth paragraphs.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
9 minutes ago
The Independent
Line of Duty: Adrian Dunbar makes surprise episode 5 revelation on GMB
‘A big clue has already been revealed,’ actor said
9 minutes ago

FTSE 100

FTSE 250

AIM

GBP/EUR

GBP/USD

BTC-GBP

CMC Crypto 200

S&P 500

DOW

CRUDE OIL

GOLD FUTURES

NIKKEI 225

HANG SENG

DAX

CAC 40

Why companies are banning constant Zoom meetings

South Africa IT Industry Report 2020 with Profiles of Dimension Data, Datatec, EOH, Spark ATM Systems, Lumbro Time Systems, Intel, IBM and Cisco - ResearchAndMarkets.com

Latest stories

Manu Tuilagi signs new Sale contract

Tech giant Darktrace heads for FTSE with £3bn IPO plan

Wagamama boss to leave in June and ‘hand on chopsticks’ to internal successor

COVID-19 Diagnostics and Kits: Global Markets

Sterling rises to two-week high vs dollar ahead of data heavy calendar

Firefighters battle to contain blaze on South Africa's Table Mountain

The Latest: EU to purchase 100 million more vaccine doses

Global Pharma, Biotech and Diagnostics Joint Venture Partnering Deal Terms and Agreements Analysis Report 2021

Nasa’s Ingenuity helicopter set for first ever controlled flight on Mars

Tesla car crash kills two in Texas

Pub and restaurant bosses launch legal battle over Covid rules

Prepayments (CK93) - Totalkredit A/S

Prepayments (CK93) - Nykredit Realkredit A/S

GLOBAL FLAVONOID MARKET FORECAST 2021-2028

Global Primary Lithium Battery Market Insights (2020 to 2025) - Companies Include Panasonic, Maxell and Toshiba Among Others - ResearchAndMarkets.com

6 best water flossers for deeper cleaning and healthy gums

Matthew McConaughey Trounces Greg Abbott In Poll For Texas Governor

The sweet moment Prince Harry and Prince William left the funeral together

New Lithium Giant Emerges to Feed Surging Battery Demand

Line of Duty: Adrian Dunbar makes surprise episode 5 revelation on GMB